Overview

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years)
Details
Lead Sponsor:
Pfizer
Treatments:
Heptavalent Pneumococcal Conjugate Vaccine